Teva Pharmaceutical Industries Ltd.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Teva Pharmaceutical Industries Ltd.
Biopharma will outline its growth goals for 2022 over the coming weeks, with J&J, Novartis, AbbVie, Merck, Roche, Biogen and Lilly among the first to report.
Hikma expects healthy prospects for its US Advair generic in 2022, despite rival Teva recently receiving FDA approval for its own version. Meanwhile, Hikma CEO Siggi Olafsson also outlined expectations for generic competition on icosapent amid ongoing API shortages.
Teva has commented on its proposed settlement of $420m with a class of investors following allegations that the firm had concealed the true nature of its increase in profits, which artificially inflated the price of Teva’s securities.
ImmPACT Bio is advancing three CAR-T technology platforms that aim to address problems such as antigen escape, off-target toxicities and the immunosuppressive tumor microenvironment.
- Generic Drugs
- OTC, Consumer
- Other Names / Subsidiaries
- ABIC Marketing Limited
- Auspex Pharmaceuticals, Inc. (Imphar AG)
- Barr Pharmaceuticals
- Bentley Pharmaceuticals
- BioGeneriX AG
- BioAssets Development Corporation
- Cephalon, Inc. (Arana Therapeutics (Peptech and EvoGenix)
- Ception Therapeutics
- ChemGenex Pharmaceuticals Limited
- CIMA Labs
- Gemin X Pharmaceuticals
- CT Arzneimittel GmbH
- Gecko Health Innovations
- IVAX Corporation
- Labrys Biologics
- MicroDose Therapeutx Inc.
- Neose Technologies, Inc.
- NuPathe, Inc.
- PLIVA HRVATSKA d.o.o.
- ratiopharm Group
- Sicor Biotech
- Representaciones e Investigaciones Médicas, S.A. de C.V.
- Taiyo Pharmaceutical Industry Co. Ltd.
- Teva Branded Pharmaceutical Products, R&D Inc.
- Teva Women's Health, Inc.
- Actavis Generics
- Anda, Inc.
- Uteron Pharma S.P.R.L.
- Teva Takeda Yakuhin Ltd.
- Teva Takeda Pharma Ltd.
- Teva Neuroscience, Inc.
- Teva Pharmaceuticals USA, Inc.
- Zeneus Pharma